BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 28860738)

  • 1. Risk factors for pulmonary arterial hypertension in patients with tuberculosis-destroyed lungs and their clinical characteristics compared with patients with chronic obstructive pulmonary disease.
    Jo YS; Park JH; Lee JK; Heo EY; Chung HS; Kim DK
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2433-2443. PubMed ID: 28860738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of the hemodynamics of pulmonary artery and right ventricular function in chronic obstructive pulmonary disease with pulmonary hypertension using cardiac magnetic resonance imaging].
    Fan Y; Guo X; Sun X; Cao X; He J; Zhu L; Chen J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Aug; 31(8):972-977. PubMed ID: 31537222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors associated with pulmonary hypertension in patients with active tuberculosis and tuberculous destroyed lung: a retrospective study.
    Liu W; Xu Y; Yang L; Zhan S; Pang K; Lin H; Qin H; Zhang P
    Sci Rep; 2024 May; 14(1):10108. PubMed ID: 38698005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study.
    Kim CJ; Yoon HK; Park MJ; Yoo KH; Jung KS; Park JW; Lim SY; Shim JJ; Lee YC; Kim YS; Oh YM; Kim S; Yoo CG
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1589-1596. PubMed ID: 28615931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Different Smoking Behavior on Pulmonary Function and Pulmonary Hypertension Among Chinese Male Patients with Chronic Obstructive Pulmonary Disease.
    Gao H; Song Y; Liu K; Lu X; Shen J; Wei S; Jiang H; Xu N
    Int J Chron Obstruct Pulmon Dis; 2024; 19():1315-1331. PubMed ID: 38895046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary function and diffusion capacity are associated with pulmonary arterial systolic pressure in the general population: The Rotterdam Study.
    Loth DW; Lahousse L; Leening MJG; Krijthe BP; Felix JF; Gall H; Hofman A; Ghofrani HA; Franco OH; Stricker BH; Brusselle GG
    Respir Med; 2017 Nov; 132():50-55. PubMed ID: 29229105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary artery pressure in chronic obstructive pulmonary disease without resting hypoxaemia.
    Lee JH; Oh YM; Seo JB; Lee YK; Kim WJ; Sheen SS; Kim TH; Lee JH; Kim EK; Lee JS; Huh JW; Lim SY; Yoon HI; Shin TR; Lee SM; Lee SY; Lee SD
    Int J Tuberc Lung Dis; 2011 Jun; 15(6):830-7. PubMed ID: 21575307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary Arterial Hypertension-Specific Drug Therapy in COPD Patients with Severe Pulmonary Hypertension and Mild-to-Moderate Airflow Limitation.
    Calcaianu G; Canuet M; Schuller A; Enache I; Chaouat A; Kessler R
    Respiration; 2016; 91(1):9-17. PubMed ID: 26492415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of tuberculosis in COPD.
    Yakar HI; Gunen H; Pehlivan E; Aydogan S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():323-329. PubMed ID: 28176901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary arterial hypertension in patients with sleep apnoea syndrome.
    Bady E; Achkar A; Pascal S; Orvoen-Frija E; Laaban JP
    Thorax; 2000 Nov; 55(11):934-9. PubMed ID: 11050263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension.
    Hajian B; De Backer J; Vos W; Van Holsbeke C; Ferreira F; Quinn DA; Hufkens A; Claes R; De Backer W
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1533-41. PubMed ID: 27462149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognosis of respiratory failure in patients with tuberculous destroyed lung.
    Park JH; Na JO; Kim EK; Lim CM; Shim TS; Lee SD; Kim WS; Kim DS; Kim WD; Koh Y
    Int J Tuberc Lung Dis; 2001 Oct; 5(10):963-7. PubMed ID: 11605892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RV stroke work in children with pulmonary arterial hypertension: estimation based on invasive haemodynamic assessment and correlation with outcomes.
    Di Maria MV; Younoszai AK; Mertens L; Landeck BF; Ivy DD; Hunter KS; Friedberg MK
    Heart; 2014 Sep; 100(17):1342-7. PubMed ID: 24780910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary artery size as a predictor of pulmonary hypertension and outcomes in patients with chronic obstructive pulmonary disease.
    Shin S; King CS; Brown AW; Albano MC; Atkins M; Sheridan MJ; Ahmad S; Newton KM; Weir N; Shlobin OA; Nathan SD
    Respir Med; 2014 Nov; 108(11):1626-32. PubMed ID: 25225149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of airflow limitation on acute exacerbations in patients with destroyed lungs by tuberculosis.
    Kim SJ; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Kim YW; Han SK; Yoo CG
    J Korean Med Sci; 2015 Jun; 30(6):737-42. PubMed ID: 26028926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hemodynamic profile in chronic obstructive pulmonary disease.
    Portillo K; Torralba Y; Blanco I; Burgos F; Rodriguez-Roisin R; Rios J; Roca J; Barberà JA
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1313-20. PubMed ID: 26203238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiopulmonary exercise test and PaO
    Skjørten I; Hilde JM; Melsom MN; Hisdal J; Hansteen V; Steine K; Humerfelt S
    Int J Chron Obstruct Pulmon Dis; 2018; 13():91-100. PubMed ID: 29339921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of right ventricular geometry and mechanics in chronic obstructive pulmonary disease patients living at high altitude.
    Güvenç TS; Kul S; Doğan C; Yıldırım BZ; Karabağ Y; Cetin R; Kaya Y; Karadağ P; Değirmencioğlu A; Balcı B
    Int J Cardiovasc Imaging; 2014 Oct; 30(7):1305-13. PubMed ID: 24950729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of chronic obstructive pulmonary disease with pulmonary hypertension on both left ventricular systolic and diastolic performance.
    Yilmaz R; Gencer M; Ceylan E; Demirbag R
    J Am Soc Echocardiogr; 2005 Aug; 18(8):873-81. PubMed ID: 16084341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidities in obstructive lung disease in Korea: data from the fourth and fifth Korean National Health and Nutrition Examination Survey.
    Park HJ; Leem AY; Lee SH; Song JH; Park MS; Kim YS; Kim SK; Chang J; Chung KS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1571-82. PubMed ID: 26300636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.